Abstract
Neuroglobin (Ngb) is expressed in the central and peripheral nervous system, cerebrospinal fluid, retina, and endocrine tissues where it is involved in binding O2 and other gasotransmitters. Several studies have highlighted its endogenous neuroprotective function. Huntington’s disease (HD), a dominant hereditary disease, is characterized by the gradual loss of neurons in discrete areas of the central nervous system. We analyzed the expression of Ngb in the brain tissue of a mouse model of HD, in order to define the role of Ngb with respect to individual cell type vulnerability in HD and to gender and age of mice. Our results showed different expressions of Ngb among neurons of a specific region and between different brain regions. We evidenced a decreased intensity of Ngb at 13 weeks of age, compared to 7 weeks of age. The double immunofluorescence and fluorescence resonance energy transfer (FRET) experiments showed that the co-localization between Ngb and huntingtin at the subcellular level was not close enough to account for a direct interaction. We also observed a different expression of Ngb in the striatum, depending on the sex and age of animals. These findings provide the first experimental evidence for an adaptive response of Ngb in HD, suggesting that Ngb may exert neuroprotective effects in HD beyond its role in reducing sensitivity to oxidative stress.
Similar content being viewed by others
References
Albin RL, Tagle DA (1995) Genetics and molecular biology of Huntington’s disease. Trends Neurosci 18:11–14. https://doi.org/10.1016/0166-2236(95)93943-R
European Community Huntington’s Disease Collaborative Study Group (1993) Ethical and social issues in presymptomatic testing for Huntington’s disease: a European Community collaborative study. J Med Genet 30:1028–1035. https://doi.org/10.1136/jmg.30.12.1028
Melone MA, Jori FP, Peluso G (2005) Huntington’s disease: new frontiers for molecular and cell therapy. Curr Drug Targets 6:43–56. https://doi.org/10.2174/1389450053344975
Perrone L, Melone MA (2008) New targets for therapy in polyglutamine (polyQ) expansion diseases. Curr Drug Ther 3:177–189. https://doi.org/10.2174/157488508785747835
Leuti A, Laurenti D, Giampà C, Montagna E, Dato C, Anzilotti S, Melone MA, Bernardi G, Fusco FR (2013) Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington’s disease. Neurobiol Dis 52:104–116. https://doi.org/10.1016/j.nbd.2012.11.016
Vidoni C, Secomandi E, Castiglioni A, Melone MAB, Isidoro C (2017) Resveratrol protects neuronal-like cells expressing mutant huntingtin from dopamine toxicity by rescuing ATG4-mediated autophagosome formation. Neurochem Int [Epub ahead of print]. https://doi.org/10.1016/j.neuint.2017.05.013
Ascenzi P, di Masi A, Leboffe L, Fiocchetti M, Nuzzo MT, Brunori M, Marino M (2016) Neuroglobin: from structure to function in health and disease. Mol Aspects Med 52:1–48. https://doi.org/10.1016/j.mam.2016.10.004
Brittain T (2012) The anti-apoptotic role of neuroglobin. Cell 1:1133–1155. https://doi.org/10.3390/cells1041133
Khan AA, Mao XO, Banwait S, Jin K, Greenberg DA (2007) Neuroglobin attenuates beta-amyloid neurotoxicity in vitro and transgenic Alzheimer phenotype in vivo. Proc Natl Acad Sci U S A 104:19114–19119. https://doi.org/10.1073/pnas.0706167104
Greenberg DA, Jin K, Khan AA (2008) Neuroglobin: an endogenous neuroprotectant. Curr Opin Pharmacol 8:20–24. https://doi.org/10.1016/j.coph.2007.09.003
Jin K, Mao XO, Xie L, Khan AA, Greenberg DA (2008) Neuroglobin protects against nitric oxide toxicity. Neurosci Lett 430:135–137. https://doi.org/10.1016/j.neulet.2007.10.031
Wang X, Liu J, Zhu H, Tejima E, Tsuji K, Murata Y, Atochin DN, Huang PL, Zhang C, Lo EH (2008) Effects of neuroglobin overexpression on acute brain injury and long-term outcomes after focal cerebral ischemia. Stroke 39:1869–1874. https://doi.org/10.1161/STROKEAHA.107.506022
Yu Z, Liu J, Guo S, Xing C, Fan X, Ning M, Yuan JC, Lo EH, Wang X (2009) Neuroglobin-overexpression alters hypoxic response gene expression in primary neuron culture following oxygen glucose deprivation. Neuroscience 162:396–403. https://doi.org/10.1016/j.neuroscience.2009.04.055
Carvalho C, Correia SC, Cardoso S, Placido AI, Candeias E, Duarte AI, Moreira PI (2015) The role of mitochondrial disturbances in Alzheimer, Parkinson and Huntington diseases. Expert Rev Neurother 15:867–884. https://doi.org/10.1586/14737175.2015.1058160
Nuzzo MT, Fiocchetti M, Totta P, Melone MA, Cardinale A, Fusco FR, Gustincich S, Persichetti F, Ascenzi P, Marino M (2016) Huntingtin polyQ mutation impairs the 17beta-estradiol/neuroglobin pathway devoted to neuron survival. Mol Neurobiol [Epub ahead of print]. https://doi.org/10.1007/s12035-016-0337-x
Wystub S, Laufs T, Schmidt M, Burmester T, Maas U, Saaler-Reinhardt S, Hankeln T, Reuss S (2003) Localization of neuroglobin protein in the mouse brain. Neurosci Lett 346:114–116. https://doi.org/10.1016/S0304-3940(03)00563-9
Franklin KBJ, Paxinos G (2007) The mouse brain in stereotaxic coordinates. 3rd ed. trove.nla.gov.au/work/9674709
Fusco FR, Martorana A, Giampa C, De March Z, Farini D, D'Angelo V, Sancesario G, Bernardi G (2004) Immunolocalization of CB1 receptor in rat striatal neurons: a confocal microscopy study. Synapse 53:159–167. https://doi.org/10.1002/syn.20047
Fusco FR, Zuccato C, Tartari M, Martorana A, De March Z, Giampa C, Cattaneo E, Bernardi G (2003) Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain. Eur J Neurosci 18:1093–1102. https://doi.org/10.1046/j.1460-9568.2003.02844.x
Amoroso MR, Matassa DS, Laudiero G, Egorova AV, Polishchuk RS, Maddalena F, Piscazzi A, Paladino S, Sarnataro D, Garbi C, Landriscina M, Esposito F (2012) TRAP1 and the proteasome regulatory particle TBP7/Rpt3 interact in the endoplasmic reticulum and control cellular ubiquitination of specific mitochondrial proteins. Cell Death Differ 19:592–604. https://doi.org/10.1038/cdd.2011.128
French AP, Mills S, Swarup R, Bennett MJ, Pridmore TP (2008) Colocalization of fluorescent markers in confocal microscope images of plant cells. Nat Protoc 3:619–628. https://doi.org/10.1038/nprot.2008.31
Albin RL, Reiner A, Anderson KD, Dure LST, Handelin B, Balfour R, Whetsell WO Jr, Penney JB, Young AB (1992) Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington’s disease. Ann Neurol 31:425–430. https://doi.org/10.1002/ana.410310412
Albin RL, Young AB, Penney JB, Handelin B, Balfour R, Anderson KD, Markel DS, Tourtellotte WW, Reiner A (1990) Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington’s disease. N Engl J Med 322:1293–1298. https://doi.org/10.1056/NEJM199005033221807
Bolam JP, Hanley JJ, Booth PA, Bevan MD (2000) Synaptic organisation of the basal ganglia. J Anat 196(Pt 4):527–542. https://doi.org/10.1046/j.1469-7580.2000.19640527.x
Vonsattel JP, Keller C, Cortes Ramirez EP (2011) Huntington’s disease—neuropathology. Handb Clin Neurol 100:83–100. https://doi.org/10.1016/B978-0-444-52014-2.00004-5
Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, MacDonald ME, Friedlander RM, Silani V, Hayden MR, Timmusk T, Sipione S, Cattaneo E (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington’s disease. Science 293:493–498. https://doi.org/10.1126/science.1059581
Liu J, Yu Z, Guo S, Lee SR, Xing C, Zhang C, Gao Y, Nicholls DG, Lo EH, Wang X (2009) Effects of neuroglobin overexpression on mitochondrial function and oxidative stress following hypoxia/reoxygenation in cultured neurons. J Neurosci Res 87:164–170. https://doi.org/10.1002/jnr.21826
Papalexi E, Persson A, Bjorkqvist M, Petersen A, Woodman B, Bates GP, Sundler F, Mulder H, Brundin P, Popovic N (2005) Reduction of GnRH and infertility in the R6/2 mouse model of Huntington’s disease. Eur J Neurosci 22:1541–1546. https://doi.org/10.1002/jnr.21826
Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493–506. https://doi.org/10.1016/S0092-8674(00)81369-0
De Marinis E, Ascenzi P, Pellegrini M, Galluzzo P, Bulzomi P, Arevalo MA, Garcia-Segura LM, Marino M (2010) 17β-estradiol—a new modulator of neuroglobin levels in neurons: role in neuroprotection against H2O2-induced toxicity. Neurosignals 18:223–235. https://doi.org/10.1159/000323906
De Marinis E, Fiocchetti M, Acconcia F, Ascenzi P, Marino M (2013) Neuroglobin upregulation induced by 17β-estradiol sequesters cytocrome c in the mitochondria preventing H2O2-induced apoptosis of neuroblastoma cells. Cell Death Dis 4:e508. https://doi.org/10.1038/cddis.2013.30
Sun Y, Jin K, Mao XO, Xie L, Peel A, Childs JT, Logvinova A, Wang X, Greenberg DA (2005) Effect of aging on neuroglobin expression in rodent brain. Neurobiol Aging 26:275–278. https://doi.org/10.1016/j.neurobiolaging.2004.03.006
Szymanski M, Wang R, Fallin MD, Bassett SS, Avramopoulos D (2010) Neuroglobin and Alzheimer’s dementia: genetic association and gene expression changes. Neurobiol Aging 31:1835–1842. https://doi.org/10.1016/j.neurobiolaging.2008.10.003
Zuccato C, Valenza M, Cattaneo E (2010) Molecular mechanisms and potential therapeutical targets in Huntington’s disease. Physiol Rev 90:905–981. https://doi.org/10.1152/physrev.00041.2009
Browne SE (2008) Mitochondria and Huntington’s disease pathogenesis: insight from genetic and chemical models. Ann N Y Acad Sci 1147:358–382. https://doi.org/10.1196/annals.1427.018
Yu Z, Liu N, Li Y, Xu J, Wang X (2013) Neuroglobin overexpression inhibits oxygen-glucose deprivation-induced mitochondrial permeability transition pore opening in primary cultured mouse cortical neurons. Neurobiol Dis 56:95–103. https://doi.org/10.1016/j.nbd.2013.04.015
Quintanilla RA, Tapia C, Perez MJ (2017) Possible role of mitochondrial permeability transition pore in the pathogenesis of Huntington disease. Biochem Biophys Res Commun 483:1078–1083. https://doi.org/10.1016/j.bbrc.2016.09.054
Sun F, Mao X, Xie L, Greenberg DA, Jin K (2013) Neuroglobin protein is upregulated in Alzheimer’s disease. J Alzheimers Dis 36:659–663. https://doi.org/10.3233/JAD-130323
Raychaudhuri S, Skommer J, Henty K, Birch N, Brittain T (2010) Neuroglobin protects nerve cells from apoptosis by inhibiting the intrinsic pathway of cell death. Apoptosis 15:401–411. https://doi.org/10.1007/s10495-009-0436-5
Fordel E, Thijs L, Martinet W, Lenjou M, Laufs T, Van Bockstaele D, Moens L, Dewilde S (2006) Neuroglobin and cytoglobin overexpression protects human SH-SY5Y neuroblastoma cells against oxidative stress-induced cell death. Neurosci Lett 410:146–151. https://doi.org/10.1016/j.neulet.2006.09.027
Acknowledgements
We thank the animal facility of the IRCCS Fondazione Santa Lucia/EBRI/CNR.
Funding
This research was supported by a grant from the Ministry of Education, Universities and Research (MIUR) (Italy) under PRIN contract #20109MXHMR_004 (to MABM), for which the authors are indebted.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All experiments were carried out in accordance with the Guide for the Care and Use of Laboratory Animals and the European Communities Council Directive of 24 November 1986 (86/609/EEC) as adopted by the Santa Lucia Foundation Animal Care and Use committee. The Santa Lucia Foundation Animal Care and Use committee specifically approved this study.
Conflict of interest
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Cardinale, A., Fusco, F.R., Paldino, E. et al. Localization of neuroglobin in the brain of R6/2 mouse model of Huntington’s disease. Neurol Sci 39, 275–285 (2018). https://doi.org/10.1007/s10072-017-3168-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-017-3168-2